Ernexa Therapeutics, Inc. (ERNA)
7.60
+1.56
(+25.83%)
USD |
NASDAQ |
May 07, 15:44
Ernexa Therapeutics SG&A Expense (TTM) : 5.162M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 87.80M |
| Quince Therapeutics, Inc. | 15.05M |
| Recursion Pharmaceuticals, Inc. | 121.94M |
| Tango Therapeutics, Inc. | 41.51M |
| Aprea Therapeutics, Inc. | 6.477M |